In this paper we describe the preparation and characterization
of magnetic nanocomposites designed for applications in targeted drug
delivery. Combining superparamagnetic behavior with proper surface
functionalization in a single entity makes it possible to have altogether
controlled location and drug loading, and release capabilities. The
colloidal vehicles consist of maghemite (γ-Fe2O3) cores surrounded by a gold shell through an intermediate
silica coating. The external Au layer confers the particles a high
degree of biocompatibility and reactive sites for the transported
drug binding. In addition, it permits to take advantage of the strong
optical resonance, making it easy to visualize the particles or even
control their payload release through temperature changes. The results
of the analysis of relaxivity demonstrate that these nanostructures
can be used as T
2 contrast agents in magnetic
resonance imaging (MRI), but the magnetic cores will be mainly useful
in manipulating the particles using external magnetic fields. We describe
how optical absorbance and electrokinetic data provide a followup
of the progress of the nanostructure formation. Additionally, these
techniques, together with confocal microscopy, are employed to demonstrate
that the component nanoparticles are capable of loading significant
amounts of the antitumor drug doxorubicin, very efficient in the chemotherapy
of a wide range of tumors. Colon adenocarcinoma cells were used to
test the in vitro release capabilities of the drug-loaded nanocomposites.